Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bliss: Venlafaxine in Japanese pediatric outpatients with depression
jRCT2031220238Active, not recruiting
- Sponsor
- Viatris
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) and persistent depressive disorder (PDD) comparing Venlafaxine with Placebo (2 arms). Started Mar 2023; status: active, not recruiting.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)
Beyond the preview
Go deeper on jRCT2031220238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220238.